Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination MeSH Descriptor Data 2025


MeSH Heading
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Tree Number(s)
D02.705.429.906.750
D03.383.742.680.245.500.600.750
D03.633.100.759.138.881.750
D13.570.230.329.525.500
D13.570.685.245.500.600.500
D26.310.423
Unique ID
D000069480
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069480
Scope Note
A pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.
Entry Term(s)
Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination
Truvada
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
0
Public MeSH Note
2016; EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE DRUG COMBINATION was indexed under DEOXYCYTIDINE and ORGANOPHOSPHORUS COMPOUNDS 2005-2015
History Note
2016 (2005)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/31
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Preferred
Truvada Narrower
page delivered in 0.153s